Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
28.57
+0.24 (0.85%)
At close: Mar 9, 2026, 4:00 PM EDT
28.62
+0.05 (0.18%)
After-hours: Mar 9, 2026, 7:01 PM EDT
HRMY Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Market Capitalization | 1,653 | 2,155 | 1,962 | 1,892 | 3,268 | 2,493 | Upgrade
|
| Market Cap Growth | -16.95% | 9.83% | 3.73% | -42.12% | 31.09% | 21.23% | Upgrade
|
| Enterprise Value | 1,046 | 1,652 | 1,737 | 1,721 | 3,155 | 2,496 | Upgrade
|
| Last Close Price | 28.57 | 37.42 | 34.41 | 32.30 | 55.10 | 42.64 | Upgrade
|
| PE Ratio | 10.54 | 13.58 | 13.49 | 14.68 | 18.01 | 72.07 | Upgrade
|
| Forward PE | 8.04 | 10.05 | 11.82 | 11.14 | 23.01 | 25.27 | Upgrade
|
| PS Ratio | 1.90 | 2.48 | 2.75 | 3.25 | 7.47 | 8.16 | Upgrade
|
| PB Ratio | 1.90 | 2.48 | 2.98 | 4.05 | 8.11 | 13.37 | Upgrade
|
| P/TBV Ratio | 2.12 | 2.76 | 3.60 | 5.74 | 13.51 | 58.54 | Upgrade
|
| P/FCF Ratio | 4.75 | 6.20 | 8.98 | 8.64 | 22.65 | 25.37 | Upgrade
|
| P/OCF Ratio | 4.75 | 6.19 | 8.93 | 8.62 | 22.62 | 25.30 | Upgrade
|
| PEG Ratio | 0.45 | 0.39 | 0.47 | 0.73 | - | - | Upgrade
|
| EV/Sales Ratio | 1.20 | 1.90 | 2.43 | 2.96 | 7.21 | 8.17 | Upgrade
|
| EV/EBITDA Ratio | 4.48 | 7.07 | 8.08 | 7.95 | 21.98 | 23.46 | Upgrade
|
| EV/EBIT Ratio | 5.02 | 7.93 | 9.10 | 8.96 | 26.25 | 28.51 | Upgrade
|
| EV/FCF Ratio | 3.01 | 4.75 | 7.95 | 7.86 | 21.87 | 25.40 | Upgrade
|
| Debt / Equity Ratio | 0.19 | 0.19 | 0.28 | 0.42 | 0.48 | 1.05 | Upgrade
|
| Debt / EBITDA Ratio | 0.72 | 0.72 | 0.84 | 0.90 | 1.34 | 1.82 | Upgrade
|
| Debt / FCF Ratio | 0.49 | 0.49 | 0.83 | 0.90 | 1.35 | 1.99 | Upgrade
|
| Net Debt / Equity Ratio | -0.70 | -0.70 | -0.43 | -0.34 | -0.32 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -2.59 | -2.59 | -1.33 | -0.73 | -0.90 | -0.36 | Upgrade
|
| Net Debt / FCF Ratio | -1.74 | -1.74 | -1.31 | -0.72 | -0.89 | -0.39 | Upgrade
|
| Asset Turnover | 0.77 | 0.77 | 0.79 | 0.78 | 0.79 | 0.71 | Upgrade
|
| Inventory Turnover | 31.60 | 31.60 | 24.97 | 25.10 | 19.13 | 13.45 | Upgrade
|
| Quick Ratio | 3.46 | 3.46 | 3.14 | 2.61 | 4.79 | 5.01 | Upgrade
|
| Current Ratio | 3.60 | 3.60 | 3.31 | 2.75 | 5.07 | 5.29 | Upgrade
|
| Return on Equity (ROE) | 20.75% | 20.75% | 25.84% | 29.63% | 61.58% | 24.39% | Upgrade
|
| Return on Assets (ROA) | 11.47% | 11.47% | 13.17% | 16.16% | 13.57% | 12.71% | Upgrade
|
| Return on Invested Capital (ROIC) | 51.58% | 48.26% | 42.39% | 48.91% | 56.97% | 76.78% | Upgrade
|
| Return on Capital Employed (ROCE) | 20.40% | 20.40% | 23.20% | 29.60% | 20.20% | 23.10% | Upgrade
|
| Earnings Yield | 9.60% | 7.36% | 7.41% | 6.81% | 5.55% | 1.39% | Upgrade
|
| FCF Yield | 21.05% | 16.14% | 11.14% | 11.58% | 4.42% | 3.94% | Upgrade
|
| Buyback Yield / Dilution | -1.17% | -1.17% | 4.15% | 1.19% | -3.19% | -129.72% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.